Leap Therapeutics(LPTX) - 2025 Q4 - Annual Results

Cypherpunk Reports Full Year 2025 Financial Results Exhibit 99.1 "2025 was a transformational year. Following a $58.88 million private placement led by Winklevoss Capital, we rebranded as Cypherpunk to become a privacy technology company with a digital asset treasury strategy focused on Zcash, while advancing sirexatamab for the treatment of patients with colorectal cancer through our Leap Therapeutics subsidiary," said Douglas E. Onsi, President and CEO of Cypherpunk. "Since we began operating as Cypherpun ...